Due to the destructive nature of COPD on patients’ lungs and well-being, timely diagnosis is key, and integrating spirometry ...

mean change from baseline FEV 1 at 12 wk: cilomilast +10 mL vs placebo -60 mL (p = 0.16) COPD = chronic obstructive pulmonary disease; FEV 1 = forced expiratory volume in 1 second; FVC = forced ...

MD: IL-33 inhibition with tozorakimab may offer clinical benefits in patients with COPD at high risk of exacerbations.

The odds for bronchodilator responsiveness significantly fell among patients who underwent spirometry testing in the ...

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated. Several ...

Connect Biopharma (CNTB) announced the online publication of results from the global Phase 2 trial of rademikibart in patients with ...

FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an ...

WE usually see celebrities polished and acting up for the camera and rarely see a glimpse of their real lives. So catching them out puffing on a vape while at the beach or outside a lavish event ...

Mar. 25, 2025 — Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor ...

Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even ...